Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device. Atlassian cookies and tracking notice, (opens new window)
/
Using OMOP and Other Real World Data Standards to Support Regulatory Submissions

    Using OMOP and Other Real World Data Standards to Support Regulatory Submissions

    Oct 01, 2025

    Project Scope 

    The scope of the project includes developing awareness of data standards specific to real-world data to support regulatory purposes. Common data models (CDMs) and taxonomies that are specific to the most commonly used real-world data sources by industry, member companies and regulatory bodies across the globe will be in scope, such as electronic health record sources, patient reported outcomes, widely accepted claims data sources, and other commonly used observational data. OMOP and the OHDSI community will be the focus, and will be evaluated against other CDMs and standards (such as PCORnet, Sentinel and CDISC).

    Project Statement 

    OMOP is fully endorsed by the EMA with a mature community and a code base, whereas other global health agencies have different guidance, with commonalities and differences. This leads to decreased quality and efficiency as data are transformed one or multiple times to match standards across regulatory bodies.

    Project Impact 

    This project plans to develop a white paper detailing emerging and mature data standards for real-world data, such as OMOP, along with why different standards work better for different data types and use cases. The white paper will also look at the maturity of different standards, and communities and code available. This project aims to initiate dialogue about using these standards for submission purposes to help transportability and other issues. 

    Project LeadsEmail

    Berber Snoeijer, ClinLine

    b.snoeijer@clinline.eu

    Alexa Parliyan, Pfizer

    Alexa.Parliyan@pfizer.com

    Sanket Kalyankar, Sumptuous Ds

    sanket.kalyankar@sumptuousds.onmicrosoft.com
    Birol Emir, PfizerBirol.Emir@pfizer.com
    Nicola Newton, PHUSE Project Coordinator 

    nicky@phuse.global 

    CURRENT STATUS (Updated Quarterly) 

    • White paper outlined
    • Started collecting content per chapter​​
    • First chapter's initial text available​

    Objectives & Deliverables

    Timelines

    White PaperQ4 2025
    , multiple selections available,
    Welcome to the PHUSE Advance Hub

    WORKING GROUPS
    Results will update as you type.
    • Working Groups
      • Data Transparency
      • Data Visualisation & Open Source Technology
      • Emerging Trends & Innovation
      • Nonclinical Topics
      • Optimizing the Use of Data Standards
      • pharmaverse
      • Real World Evidence
        • Applying Advanced Data Privacy Methods to Real World Data (RWD)
        • Estimands for RWD/RWE
        • Missing Data Imputation in RWD Exploration of Multiple Techniques on Open-Source Data
        • Quality and Reusability of Real World Data
        • RWD Guideline for Programming and Analysis Processes
        • Submitting Real World Data
        • Using OMOP and Other Real World Data Standards to Support Regulatory Submissions
      • Risk Based Quality Management
      • Safety Analytics
    • Hot Topics
    • Useful Information
    • Deliverables
    • Working Groups Events
    • Working Groups Report – Q3 2025
    • Working Groups Archive
    • Working Groups Events Archive

      You‘re viewing this with anonymous access, so some content might be blocked.
      {"serverDuration": 10, "requestCorrelationId": "a8d9a23c2a014c68b9c22630026e1a02"}